Wednesday, February 10, 2010, 5:07am EST - Canadian Markets open in 4 hours and 23 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

PDI, Inc. (PDII)

 On Feb 9: 5.18 USD   0.00 (0.00%)  
MORE ON PDII
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
PDI, Inc. (NGM:PDII) Delayed quote dataEdit
Last Trade: 5.18 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 5.18
Open: N/A
Bid: N/A
Ask: N/A
1y Target Est: N/A
Day's Range: N/A - N/A
52wk Range: 2.80 - 6.25
Volume: 0
Avg Vol (3m): 38,346
Market Cap: 73.61M
P/E (ttm): N/A
EPS (ttm): -2.29
Div & Yield: N/A (N/A%)
PDI, Inc. (PDII)
1d  5d  3m  6m  1y  2y  5y  max 
 Add PDII to Portfolio   Download Data

HEADLINES
• PDI to Present at the UBS 20th Annual Global Healthcare Services Conference
PRNewswire (Tue, Feb 2)
• PDI INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Fri, Jan 22)
• PDI Mourns Death of Board Member Dr. Joseph T. Curti
PRNewswire (Thu, Jan 14)
• PDI Awarded New Pharmaceutical Services Contract With Top 10 Pharmaceutical Company
PRNewswire (Mon, Jan 11)
• PDI Announces Business Win With Expected Annual Revenue of $33 Million
PRNewswire (Thu, Jan 7)
• PDI Announces New Pharmaceutical Services Business Win With a Top 5 Pharmaceutical Company
PRNewswire (Wed, Dec 23)
• PDI INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
EDGAR Online (Fri, Dec 4)
• PDI INC Financials
EDGAR Online Financials (Wed, Nov 11)
• PDI INC. 2009 Third Quarter Financial Results Call scheduled for 4:30 pm ET today
CCBN (Thu, Nov 5)
• PDI INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Thu, Nov 5)
More Headlines for PDII...
ANALYST
EPS Est (next year) (Dec-09) : -1.16
EPS Est (in 2 years) (Dec-10) : -0.35
Avg Rec (current)*: 3.0
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
PDI, Inc. provides outsourced pharmaceutical sales and marketing services to biopharmaceutical and life sciences industries in the United States. It offers a range of sales support services, as well as marketing research, physician interaction, an...

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices